Ledger.Open graph →
SEC Form D · filed March 19, 2021

Graphite Bio, Inc

Offering
$150.7M
Sold
$150.7M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SOUTH SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Perry Karsen · SOUTH SAN FRANCISCO, CADirectorAbraham Bassan · SOUTH SAN FRANCISCO, CADirectorJosh Lehrer · SOUTH SAN FRANCISCO, CAExec · DirectorKatherine Stultz · SOUTH SAN FRANCISCO, CAExecPhilip Gutry · SOUTH SAN FRANCISCO, CAExecJerel Davis · Cleveland, OHDirectorJoe Jimenez · SOUTH SAN FRANCISCO, CADirectorMatthew Porteus · SOUTH SAN FRANCISCO, CADirectorCarlo Rizzuto · New York, NYDirectorMaria Grazia Roncarolo · SOUTH SAN FRANCISCO, CADirectorPerry Karsen · Cambridge, MADirectorAbraham Bassan · SOUTH SAN FRANCISCO, CADirectorJosh Lehrer · SOUTH SAN FRANCISCO, CAExec · DirectorKatherine Stultz · SOUTH SAN FRANCISCO, CAExecPhilip Gutry · SOUTH SAN FRANCISCO, CAExecJerel Davis · Cleveland, OHDirectorJoe Jimenez · SOUTH SAN FRANCISCO, CADirectorMatthew Porteus · SOUTH SAN FRANCISCO, CADirectorCarlo Rizzuto · New York, NYDirectorMaria Grazia Roncarolo · SOUTH SAN FRANCISCO, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗